'Just a repeat': When drug monitoring is indicated

Australian Family Physician

Volumn 42, Issue 1, 2013, Pages 18-22

  Lucas, Catherine ^a   Donovan, Peter ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Anticonvulsants; Digoxin; Drug monitoring; Lithium

Indexed keywords

ANTICONVULSIVE AGENT; CARDIOTONIC AGENT; DIGOXIN; LITHIUM; TRANQUILIZER;

BLOOD; DRUG MONITORING; GENERAL PRACTICE; HUMAN; PROCEDURES;

ANTICONVULSANTS; ANTIMANIC AGENTS; CARDIOTONIC AGENTS; DIGOXIN; DRUG MONITORING; GENERAL PRACTICE; HUMANS; LITHIUM;

EID: 84874669961     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Patullo C, Donovan P, Kubler P, editors. RBWH prescribing guidelines. Brisbane: Queensland Health, 2012.
2. Birkett DJ. Therapeutic drug monitoring. Australian Prescriber 1997;20:9-11.
3. Begg EJ. Instant clinical pharmacology. 2nd edn. Victoria: Blackwell Publishing, 2008.
4. Ghiculescu RA. Therapeutic drug monitoring: which drugs, why, when and how to do it. Aust Prescr 2008;31:42-4.
5. Gross A. Best practice in therapeutic drug monitoring. Br J Clin Pharmacol 2001;52:5-10S.
6. Rossi S, editor. Australian Medicines Handbook. Adelaide: Australian Medicines Handbook Pty Ltd, 2012.
7. Begg EJ. Instant clinical pharmacology. 1st edn. Victoria: Blackwell Publishing, 2003.
8. Baxter K, editor. Stockley's drug interactions: a source book of interactions,their mechanisms, clinical importance and management. 9th edn. Pharmaceutical Press, 2010.
9. eTG complete. Therapeutic Guidelines Limited. Available at https://online-tg-orgau. cknservices.dotsec.com/ip/ [Accessed 6 August 2012].
10. Eadie MJ. Therapeutic drug monitoring - antiepileptic drugs. Br J Clin Pharmacol 2001;52:11-20S.
11. Tomson T, Dahl ML, Kimland E. Therapeutic monitoring of antiepileptic drugs for epilepsy (review). The Cochrane Collaboration 2010;1-16.
12. Campbell TJ, Williams KM. Therapeutic drug monitoring: antiarrhythmic drugs. Br J Clin Pharmacol 2001;52:21-34S.
13. Rogers NM, Jones TE, Morris RG. Frequently discordant results from therapeutic drug monitoring for digoxin: clinical confusion for the prescriber. Intern Med J 2010;40:52-6.
14. Morris R, Frewin D, Saccoia N, Goldsworthy W, Jeffries W, McPhee A. Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods. Eur J Clin Pharmacol 1990;39:359-63.
15. S teimer W, Muller C, Eber B. Digoxin assays: frequent, substantial, and potentially dangerous interference by spironolactone, canrenone, and other steroids. Clin Chem 2002;48:507-16.
16. Dasgupta A, Wu S, Actor J, Olsen M, Well A, Datta P. Significant variation. Am J Clin Pathol 2003;119:298-303.
17. MIMS Online, 2012. Available at www-mimsonline-com-au.ckinservices.dotsec. com/Search/Search.aspx [Accessed 6 August 2012].
18. Amdisen A. Clinical features and management of lithium poisoning. Med Toxicol 1988;3:18-32.